Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Scaffidi P (2016) Histone H1 alterations in cancer
Use of an endotoxin-free peptide is critical in laboratory environments, as endotoxin interference can significantly alter signaling data and immune-related assay outcomes
Missing a day or two occasionally is unlikely to meaningfully set back progress, but frequent inconsistency slows the cumulative process
Dec 7 2017
Theres a newer peptide called PDA, or pentadeca arginate, that has a very similar molecular structure as BPC-157, but instead of it being an acetate, its an arginate essentially just swapping out one amino acid for another
human clinical trials ongoing as of 2026 Search volume: 165,000 monthly US searches most searched non-weight-loss peptide Legal status: Category 1 compounding (legal under physician prescription, as of February 2026) Administration: Subcutaneous injection or oral/sublingual (gut applications) An honest note on the evidence: The majority of BPC-157 research has been conducted in animal models rats and mice primarily
US$ 20.82
US$ 26.64
US$ 22.13
US$ 28.86
US$ 23.54
